![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/12 | |
A61K 31/551 | |||
A61P 9/10 |
(11) | Number of the document | 1818329 |
(13) | Kind of document | T |
(96) | European patent application number | 05811715.1 |
Date of filing the European patent application | 2005-11-29 | |
(97) | Date of publication of the European application | 2007-08-15 |
(45) | Date of publication and mention of the grant of the patent | 2010-04-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2005/021844 |
Date | 2005-11-29 |
(87) | Number | WO 2006/057397 |
Date | 2006-06-01 |
(30) | Number | Date | Country code |
2004344271 | 2004-11-29 | JP |
(72) |
OHSHIMA, Takeshi, JP
HIDAKA, Hiroyoshi, JP
SHIRATSUCHI, Masami, JP
ONOGI, Kazuhiro, JP
ODA, Toshiaki, JP
|
(73) |
Kowa Company, Ltd.,
6-29, Nishiki 3-chome, Naka-ku Nagoya-shi, Aichi-ken 460-8625,
JP
D. Western Therapeutics Institute, Inc., 8th Floor, 18 KT Building 18-11, Nishiki 1-chome, Naka-ku, Nagoya-shi, Aichi 460-0003, JP |
(54) | (S)-(-)-1-(4-FLUOROISOQUINOLIN-5-YL)SULFONYL-2METHYL-1,4HOMOPIPERAZINE HYDROCHLORIDE DIHYDRATE |
(S)-(-)-1-(4-FLUOROISOQUINOLIN-5-YL)SULFONYL-2METHYL-1,4HOMOPIPERAZINE HYDROCHLORIDE DIHYDRATE |